PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 62 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,591 | -17.0% | 158,790 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $317,580 | +13.0% | 158,790 | +18.7% | 0.01% | +14.3% |
| Q1 2023 | $280,959 | +53.3% | 133,790 | 0.0% | 0.01% | +40.0% |
| Q4 2022 | $183,292 | +31.9% | 133,790 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $139,000 | -19.7% | 133,790 | -15.7% | 0.00% | 0.0% |
| Q2 2022 | $173,000 | +458.1% | 158,790 | +451.5% | 0.00% | +300.0% |
| Q1 2022 | $31,000 | -60.3% | 28,790 | -51.1% | 0.00% | 0.0% |
| Q3 2021 | $78,000 | -89.6% | 58,890 | -85.0% | 0.00% | -92.3% |
| Q2 2021 | $752,000 | -44.3% | 393,890 | +30.2% | 0.01% | -48.0% |
| Q1 2021 | $1,350,000 | +74.9% | 302,591 | +42.3% | 0.02% | +56.2% |
| Q4 2020 | $772,000 | -6.2% | 212,591 | 0.0% | 0.02% | -15.8% |
| Q3 2020 | $823,000 | +24.5% | 212,591 | +22.0% | 0.02% | +46.2% |
| Q2 2020 | $661,000 | +214.8% | 174,291 | +94.8% | 0.01% | +160.0% |
| Q1 2020 | $210,000 | – | 89,492 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 2,470,332 | $8,967,000 | 6.83% |
| Psagot Value Holdings Ltd. | 470,255 | $1,707,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 212,591 | $772,000 | 0.02% |
| UBS OCONNOR LLC | 150,000 | $544,000,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 10,042 | $36,000 | 0.01% |
| Renaissance Technologies | 488,634 | $1,774,000 | 0.00% |
| Squarepoint Ops LLC | 22,068 | $80,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 222 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 50,280 | $183,000 | 0.00% |